Compare · AFAC vs CAH
AFAC vs CAH
Side-by-side comparison of Arena Fortify Acquisition Corp. (AFAC) and Cardinal Health Inc. (CAH): market cap, price performance, sector, and recent activity on the wire.
Summary
- AFAC operates in Miscellaneous, while CAH operates in Health Care - the two are in different parts of the market.
- CAH is the larger of the two at $55.33B, about 258.7x AFAC ($213.9M).
- CAH has hit the wire 30 times in the past 4 weeks while AFAC has been quiet.
- CAH has more recent analyst coverage (25 ratings vs 0 for AFAC).
- Company
- Arena Fortify Acquisition Corp.
- Cardinal Health Inc.
- Price
- $10.29+0.29%
- $238.68+0.30%
- Market cap
- $213.9M
- $55.33B
- 1M return
- -
- +2.53%
- 1Y return
- -
- +61.67%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 0
- 30
- Recent ratings
- 0
- 25
Arena Fortify Acquisition Corp.
Arena Fortify Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on acquisition candidates within the natural resources industry. The company was incorporated in 2021 and is based in New York, New York.
Cardinal Health Inc.
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Latest AFAC
- SEC Form SC 13G/A filed by Arena Fortify Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Arena Fortify Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Arena Fortify Acquisition Corp. (Amendment)
- SEC Form 4 filed by Arena Fortify Sponsor Llc
- SEC Form 15-12G filed by Arena Fortify Acquisition Corp.
- Arena Fortify Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits
- Arena Fortify Acquisition Corp. Obtains Stockholder Approval to Terminate Before Year-End
- SEC Form 25-NSE filed by Arena Fortify Acquisition Corp.
- SEC Form 25-NSE filed by Arena Fortify Acquisition Corp.
- SEC Form 25-NSE filed by Arena Fortify Acquisition Corp.
Latest CAH
- Chief Accounting Officer Scherer Mary C. sold $546,473 worth of shares (2,302 units at $237.39), decreasing direct ownership by 45% to 2,811 units (SEC Form 4)
- Chief Executive Officer Hollar Jason M. sold $29,375,516 worth of shares (124,529 units at $235.89), decreasing direct ownership by 40% to 190,603 units (SEC Form 4)
- CEO, GMPD Segment Mason Stephen M sold $8,274,117 worth of shares (35,000 units at $236.40), decreasing direct ownership by 66% to 18,061 units (SEC Form 4)
- CEO, PSS Segment Weitzman Deborah sold $1,731,524 worth of shares (7,354 units at $235.45), decreasing direct ownership by 9% to 77,901 units (SEC Form 4)
- Chief Financial Officer Alt Aaron E sold $9,926,140 worth of shares (42,000 units at $236.34), decreasing direct ownership by 67% to 20,495 units (SEC Form 4)
- Chief Legal/Compliance Officer Mayer Jessica L sold $6,952,485 worth of shares (29,436 units at $236.19), decreasing direct ownership by 47% to 33,076 units (SEC Form 4)
- Chief Information Officer Greene Michelle D. sold $2,746,187 worth of shares (11,650 units at $235.72), decreasing direct ownership by 53% to 10,330 units (SEC Form 4)
- RBC Capital Mkts initiated coverage on Cardinal Health with a new price target
- CEO, PSS Segment Weitzman Deborah was granted 7,314 shares and covered exercise/tax liability with 29,759 shares, decreasing direct ownership by 21% to 85,255 units (SEC Form 4) (for tax liability)
- CEO, GMPD Segment Mason Stephen M was granted 5,868 shares and covered exercise/tax liability with 25,289 shares, decreasing direct ownership by 27% to 53,061 units (SEC Form 4) (tax liability)